Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.44 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 4/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.32 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16744084 | 0.91 | TSHR (0.45) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL1868365 | 0.84 | TSHR (0.47) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL12402259 | 0.82 | ALDH1A1 (0.35) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL12928030 | 0.81 | TSHR (0.52) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL4273637 | 0.81 | SMN1; SMN2 (0.47) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL5266266 | 0.76 | TSHR (0.47) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL5266721 | 0.76 | TSHR (0.47) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL188286 | 0.76 | TSHR (0.47) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL230991 | 0.76 | TSHR (0.47) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL16977255 | 0.75 | TSHR (0.63) | TSHRMAPK1SMN1; SMN2ALDH1A1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8349944-B2 | Polymer dispersion in a reactive organic medium, preparation method and uses | SAINT-GOBAIN ADFORS (FR) | 2013-01-08 | — | — | US | disclosed |
| US-8212471-B2 | Light emitting device and electronic equipment provided with the light emitting device | SEIKO EPSON CORPORATION (JP) | 2012-07-03 | — | — | US | disclosed |
| US-7910226-B2 | Porous semiconductor layer formation material | SEIKO EPSON CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7829639-B2 | photopolymerizable bis(glycidyl-substituted-diphenylamino) compounds; polyepoxides; organic light emitting; electroluminescent; thin film transistor; switch; charge transfer; high reliability; solubility | SEIKO EPSON CORPORATION (JP) | 2010-11-09 | — | — | US | disclosed |
| US-20090214864-A1 | POLYMER DISPERSION IN A REACTIVE ORGANIC MEDIUM, PREPARATION METHOD AND USES | SAINT-GOBAIN VETROTEX FRANCE S.A. (FR) | 2009-08-27 | — | — | US | disclosed |
| US-20090140635-A1 | Porous semiconductor layer formation material | SEIKO EPSON CORPORATION (JP) | 2009-06-04 | — | — | US | disclosed |
| US-20090102359-A1 | Light emitting device and electronic equipment provided with the light emitting device | SEIKO EPSON CORPORATION (JP) | 2009-04-23 | — | — | US | disclosed |
| US-20070286997-A1 | Material Composition for Conductive Layers in Electronic Devices | SEIKO EPSON CORPORATION (JP) | 2007-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070286997-A1 | Material Composition for Conductive Layers in Electronic Devices | C1S, KCNH3, SLC9A2 | TSHR 4212/4885MAPK1 556/4885SMN1; SMN2 2154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.